EFFECT OF ATENOLOL OR ENALAPRIL ON DIURNAL CHANGES OF BLOOD-PRESSURE IN JAPANESE MILD TO MODERATE HYPERTENSIVES - A DOUBLE-BLIND, RANDOMIZED, CROSSOVER TRIAL

被引:0
|
作者
TAKABATAKE, T
OHTA, H
YAMAMOTO, Y
ISHIDA, Y
HARA, H
NAKAMURA, S
TAKAKUWA, H
KOBAYASHI, K
机构
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This randomised, double-blind, crossover study compared enalapril 5 mg, and atenolol 50 mg, each dosed once daily for 4 weeks, and investigated casual and diurnal BP changes using 24 hour ambulatory BP monitoring. Both atenolol and enalapril satisfactorily lowered BP during the day and no excessive falls occurred at night. The tendency for BP to increase during the day and decrease at night was maintained during both active periods. Pulse rate was reduced only by atenolol throughout 24 hours. The BP increase observed 2 hours after rising in the morning was suppressed by atenolol but not by enalapril. Both drugs reduced the rates of systolic (greater-than-or-equal-to 160 mmHg) and diastolic (greater-than-or-equal-to 95 mmHg) BP increases to half of those during placebo. The frequency with which diastolic BP increased above these limits was less during the atenolol period. The difference in BP between a hospital casual reading and the mean 24 hour ambulatory reading was reduced only by atenolol. Furthermore only atenolol suppressed the BP and pulse rate increases on exercise.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [1] A DOUBLE-BLIND CROSSOVER TRIAL OF ATENOLOL, ENALAPRIL AND THE FIXED COMBINATION OF ATENOLOL AND NIFEDIPINE IN MILD AND MODERATE HYPERTENSION
    JACKSON, G
    THIRKETTLE, JL
    TAYLOR, DJE
    JACKSON, PG
    BRENNANDROPER, D
    VELLA, R
    MANIVANNAN, A
    FLORA, HK
    GUPTA, S
    CHAPMAN, CM
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1993, 47 (02): : 66 - 70
  • [2] RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF POTASSIUM ON BLOOD-PRESSURE IN NORMAL SUBJECTS
    KHAW, KT
    THOM, S
    LANCET, 1982, 2 (8308): : 1127 - 1129
  • [3] EFFECT OF FISH OIL SUPPLEMENTATION ON BLOOD-PRESSURE - A DOUBLE-BLIND RANDOMIZED CONTROLLED CROSSOVER TRIAL
    WILT, TJ
    LOFGREN, RP
    NICHOL, KN
    ECKFELDT, J
    CLINICAL RESEARCH, 1989, 37 (02): : A784 - A784
  • [4] BLOOD-PRESSURE RESPONSE TO ORAL CALCIUM IN PERSONS WITH MILD TO MODERATE HYPERTENSION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL
    MCCARRON, DA
    MORRIS, CD
    ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) : 825 - 831
  • [5] THE ACUTE EFFECT OF PHENYLPROPANOLAMINE AND BROMPHENIRAMINE ON BLOOD-PRESSURE IN CONTROLLED HYPERTENSION - A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL
    PETRULIS, AS
    IMPERIALE, TF
    SPEROFF, T
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1991, 6 (06) : 503 - 506
  • [6] CAPTOPRIL COMPARED TO ATENOLOL IN MILD TO MODERATE HYPERTENSION IN A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
    HAVINGA, TK
    TENBERGE, BS
    MAY, JF
    SCHUURMAN, FH
    VANDERVEUR, E
    WESSELING, H
    NETHERLANDS JOURNAL OF MEDICINE, 1991, 38 (1-2): : 13 - 17
  • [7] QUALITY-OF-LIFE IN HYPERTENSIVES TREATED WITH ATENOLOL OR CAPTOPRIL - A DOUBLE-BLIND CROSSOVER TRIAL
    PALMER, AJ
    FLETCHER, AE
    RUDGE, PJ
    ANDREWS, CD
    CALLAGHAN, TS
    BULPITT, CJ
    JOURNAL OF HYPERTENSION, 1992, 10 (11) : 1409 - 1416
  • [8] DOUBLE-BLIND CROSSOVER COMPARISON OF PINDOLOL, METOPROLOL, ATENOLOL AND LABETALOL IN MILD TO MODERATE HYPERTENSION
    MCNEIL, JJ
    LOUIS, WJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 : S163 - S166
  • [9] CAPTOPRIL AT 50-MG AS WELL AS AT 100-MG ONCE A DAY REDUCES BLOOD-PRESSURE FOR UP TO 24-H - A DOUBLE-BLIND RANDOMIZED CROSSOVER STUDY IN MILD TO MODERATE HYPERTENSIVES
    SALVETTI, A
    CIRCO, A
    RACITI, S
    GULIZIA, M
    CARDILLO, R
    MICELI, S
    BOTTA, G
    JOURNAL OF HYPERTENSION, 1988, 6 : S666 - S668
  • [10] DOUBLE-BLIND COMPARISON OF TIAPAMIL AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE HYPERTENSION - A MULTICENTER TRIAL
    SYKULSKI, R
    KELLER, N
    STORM, T
    STOKKE, O
    MYHRE, T
    HIMANEN, P
    QUITZAU, K
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (03) : 427 - 431